Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
The use of erdafitinib was associated with an objective tumor response in 40% of previously treated patients who had locally advanced and unresectable or metastatic urothelial c...
Publications
2 shownEnfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who had previousl...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,298
- Institution
- Marqués de Valdecilla University Hospital
External Links
Identifiers
- ORCID
- 0000-0001-8571-7163
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.